The Novo and Immunocore-backed cancer treatment developer has targeted $150m from a Nasdaq IPO, filing seven months after a $104m series A round.

Nabriva, which is developing antibiotics for drug-resistant infections, has now raised more than $190m in total and will advance its lead candidate into Phase 3 studies.

French electricity supply company GDF Suez has invested in Redbird, a company that analyses data captured by civilian drones.

Partech Ventures has followed its $32m Partech Entrepreneur I fund with a corporate-backed $65m second fund, the largest dedicated seed fund in Europe.

Investment bank UBS and accelerator Level39 have partnered to set up a programme aimed at developing innovative financial technology.